Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromatin | 21 | 2023 | 2951 | 1.530 |
Why?
|
Receptors, Androgen | 15 | 2024 | 1077 | 1.220 |
Why?
|
Central Serous Chorioretinopathy | 2 | 2022 | 27 | 0.980 |
Why?
|
Paraffin Embedding | 3 | 2020 | 302 | 0.940 |
Why?
|
Tissue Fixation | 3 | 2020 | 241 | 0.940 |
Why?
|
Gene Expression Regulation, Neoplastic | 29 | 2024 | 8519 | 0.910 |
Why?
|
Transcription Factors | 19 | 2024 | 12121 | 0.860 |
Why?
|
Enhancer Elements, Genetic | 8 | 2021 | 1363 | 0.800 |
Why?
|
Epigenesis, Genetic | 16 | 2024 | 3782 | 0.700 |
Why?
|
Histones | 11 | 2022 | 2577 | 0.660 |
Why?
|
Prostatic Neoplasms | 15 | 2024 | 11095 | 0.650 |
Why?
|
Lysine | 4 | 2020 | 992 | 0.590 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 339 | 0.580 |
Why?
|
Workflow | 2 | 2021 | 851 | 0.560 |
Why?
|
Cell Line, Tumor | 41 | 2024 | 16945 | 0.550 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2023 | 3631 | 0.530 |
Why?
|
Sequence Analysis, RNA | 6 | 2023 | 2018 | 0.530 |
Why?
|
Drug Resistance, Neoplasm | 11 | 2024 | 5292 | 0.510 |
Why?
|
Histone Code | 1 | 2016 | 158 | 0.490 |
Why?
|
Gene Expression Profiling | 11 | 2023 | 9410 | 0.420 |
Why?
|
Computational Biology | 4 | 2023 | 3510 | 0.420 |
Why?
|
Breast Neoplasms | 16 | 2024 | 20985 | 0.410 |
Why?
|
Sequence Analysis, DNA | 7 | 2023 | 4735 | 0.390 |
Why?
|
Chromatin Immunoprecipitation | 6 | 2017 | 855 | 0.380 |
Why?
|
Software | 6 | 2023 | 4426 | 0.380 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 6 | 2022 | 164 | 0.360 |
Why?
|
Small Cell Lung Carcinoma | 3 | 2024 | 422 | 0.360 |
Why?
|
Neoplasms | 10 | 2023 | 22083 | 0.360 |
Why?
|
Cell Proliferation | 17 | 2024 | 10425 | 0.360 |
Why?
|
Signal Transduction | 16 | 2024 | 23397 | 0.330 |
Why?
|
Acetylation | 7 | 2020 | 1054 | 0.330 |
Why?
|
Formaldehyde | 3 | 2023 | 358 | 0.320 |
Why?
|
Up-Regulation | 4 | 2024 | 4116 | 0.320 |
Why?
|
SOX9 Transcription Factor | 2 | 2021 | 145 | 0.320 |
Why?
|
Leukemia | 3 | 2024 | 1522 | 0.310 |
Why?
|
Epigenomics | 6 | 2024 | 940 | 0.310 |
Why?
|
Chromosomal Proteins, Non-Histone | 4 | 2024 | 726 | 0.310 |
Why?
|
Xenograft Model Antitumor Assays | 10 | 2024 | 3590 | 0.300 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2024 | 1135 | 0.290 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2022 | 2204 | 0.290 |
Why?
|
Mice | 36 | 2024 | 81402 | 0.270 |
Why?
|
Cell Transformation, Neoplastic | 7 | 2024 | 2821 | 0.270 |
Why?
|
Transcription, Genetic | 9 | 2020 | 7597 | 0.250 |
Why?
|
Cyclin-Dependent Kinase 4 | 4 | 2022 | 556 | 0.250 |
Why?
|
RNA, Messenger | 2 | 2018 | 12785 | 0.240 |
Why?
|
Histone Demethylases | 2 | 2024 | 320 | 0.240 |
Why?
|
Animals | 44 | 2024 | 168253 | 0.230 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2024 | 43 | 0.230 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2024 | 138 | 0.230 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2022 | 1085 | 0.220 |
Why?
|
Nuclear Proteins | 6 | 2023 | 5794 | 0.220 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2022 | 790 | 0.220 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13312 | 0.220 |
Why?
|
Transcriptional Activation | 4 | 2022 | 1753 | 0.220 |
Why?
|
p21-Activated Kinases | 1 | 2024 | 128 | 0.220 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 77 | 0.220 |
Why?
|
Glycocalyx | 1 | 2024 | 95 | 0.210 |
Why?
|
Cell Differentiation | 7 | 2024 | 11526 | 0.210 |
Why?
|
Prostate | 6 | 2023 | 1765 | 0.210 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2022 | 779 | 0.210 |
Why?
|
Humans | 89 | 2024 | 760437 | 0.200 |
Why?
|
RNA-Binding Proteins | 2 | 2022 | 1897 | 0.200 |
Why?
|
HMGN1 Protein | 2 | 2020 | 27 | 0.200 |
Why?
|
Receptors, Estrogen | 3 | 2022 | 2204 | 0.200 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2020 | 1766 | 0.200 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2021 | 2911 | 0.200 |
Why?
|
SOXB1 Transcription Factors | 2 | 2021 | 286 | 0.200 |
Why?
|
Alternative Splicing | 2 | 2019 | 1091 | 0.200 |
Why?
|
Brain Neoplasms | 4 | 2024 | 9003 | 0.190 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2021 | 345 | 0.190 |
Why?
|
Cell Lineage | 6 | 2024 | 2539 | 0.190 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 191 | 0.190 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2020 | 30 | 0.180 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2020 | 37 | 0.180 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2023 | 147 | 0.180 |
Why?
|
Lasers | 2 | 2022 | 951 | 0.180 |
Why?
|
Fixatives | 1 | 2020 | 91 | 0.180 |
Why?
|
Esophageal Neoplasms | 2 | 2021 | 1646 | 0.180 |
Why?
|
Azepines | 3 | 2020 | 329 | 0.180 |
Why?
|
Pyelonephritis | 1 | 2020 | 75 | 0.180 |
Why?
|
Androgen Antagonists | 3 | 2022 | 1407 | 0.180 |
Why?
|
Mutation | 10 | 2024 | 30025 | 0.180 |
Why?
|
Protein Binding | 8 | 2021 | 9340 | 0.180 |
Why?
|
Cyclic AMP Response Element-Binding Protein A | 1 | 2019 | 21 | 0.170 |
Why?
|
Fluorescein Angiography | 2 | 2022 | 1051 | 0.170 |
Why?
|
Oncogene Proteins | 2 | 2020 | 718 | 0.170 |
Why?
|
Ribonucleoside Diphosphate Reductase | 1 | 2019 | 32 | 0.170 |
Why?
|
DNA-Binding Proteins | 6 | 2024 | 9598 | 0.160 |
Why?
|
Transcription Factor AP-1 | 1 | 2020 | 321 | 0.160 |
Why?
|
Angiomyolipoma | 1 | 2020 | 186 | 0.160 |
Why?
|
Proto-Oncogene Proteins | 4 | 2022 | 4509 | 0.160 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2019 | 736 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 251 | 0.160 |
Why?
|
Receptor, erbB-2 | 3 | 2024 | 2553 | 0.160 |
Why?
|
Androgen Receptor Antagonists | 1 | 2019 | 125 | 0.160 |
Why?
|
Deoxyribonuclease I | 3 | 2014 | 224 | 0.160 |
Why?
|
Quinolines | 1 | 2024 | 764 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2018 | 367 | 0.160 |
Why?
|
Ureteral Obstruction | 1 | 2020 | 293 | 0.160 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2020 | 259 | 0.160 |
Why?
|
Stromal Cells | 1 | 2024 | 1330 | 0.160 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 528 | 0.150 |
Why?
|
RNA | 3 | 2023 | 2721 | 0.150 |
Why?
|
Carcinoma, Lobular | 1 | 2022 | 481 | 0.150 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 48 | 0.150 |
Why?
|
Antineoplastic Agents | 8 | 2022 | 13616 | 0.150 |
Why?
|
Mediator Complex | 2 | 2020 | 106 | 0.150 |
Why?
|
Databases, Genetic | 3 | 2016 | 1738 | 0.150 |
Why?
|
Trisomy | 1 | 2018 | 260 | 0.140 |
Why?
|
Triazoles | 3 | 2020 | 903 | 0.140 |
Why?
|
Neuroendocrine Tumors | 2 | 2021 | 642 | 0.140 |
Why?
|
Retinoblastoma-Like Protein p107 | 1 | 2017 | 71 | 0.140 |
Why?
|
Androgens | 1 | 2024 | 1282 | 0.140 |
Why?
|
Estrogen Receptor alpha | 2 | 2018 | 581 | 0.140 |
Why?
|
Gene Expression Regulation | 5 | 2020 | 11900 | 0.140 |
Why?
|
Genome | 2 | 2022 | 1739 | 0.130 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 478 | 0.130 |
Why?
|
Astrocytoma | 1 | 2020 | 775 | 0.130 |
Why?
|
Cell Nucleus | 2 | 2022 | 2906 | 0.130 |
Why?
|
Photochemotherapy | 1 | 2022 | 823 | 0.130 |
Why?
|
Histone Deacetylases | 1 | 2020 | 719 | 0.130 |
Why?
|
Oncogenes | 2 | 2022 | 1223 | 0.130 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 304 | 0.130 |
Why?
|
Receptors, Glucocorticoid | 1 | 2017 | 303 | 0.130 |
Why?
|
E2F1 Transcription Factor | 1 | 2015 | 178 | 0.130 |
Why?
|
Deoxyribonucleases | 1 | 2016 | 211 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2024 | 2058 | 0.120 |
Why?
|
Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
Binding Sites | 3 | 2019 | 6042 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1611 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2024 | 2008 | 0.120 |
Why?
|
Hepatocytes | 1 | 2022 | 1232 | 0.120 |
Why?
|
NF-kappa B | 1 | 2023 | 2485 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2021 | 4575 | 0.120 |
Why?
|
Male | 35 | 2024 | 360035 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2019 | 799 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 559 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1351 | 0.110 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2646 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2022 | 696 | 0.110 |
Why?
|
Inheritance Patterns | 1 | 2016 | 340 | 0.110 |
Why?
|
Quality Control | 1 | 2016 | 826 | 0.110 |
Why?
|
Cluster Analysis | 2 | 2018 | 2711 | 0.110 |
Why?
|
Sequence Alignment | 1 | 2018 | 2180 | 0.110 |
Why?
|
Base Sequence | 3 | 2021 | 12449 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2013 | 48 | 0.110 |
Why?
|
DNA Repair | 2 | 2022 | 2044 | 0.110 |
Why?
|
Immunotherapy | 4 | 2023 | 4649 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1347 | 0.110 |
Why?
|
Disease Progression | 4 | 2024 | 13484 | 0.110 |
Why?
|
Models, Genetic | 2 | 2020 | 3445 | 0.110 |
Why?
|
Cell Survival | 5 | 2022 | 5790 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2022 | 2895 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2019 | 1146 | 0.100 |
Why?
|
Phenylthiohydantoin | 3 | 2019 | 205 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2017 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1406 | 0.100 |
Why?
|
Tomography, Optical Coherence | 2 | 2022 | 2907 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1889 | 0.100 |
Why?
|
DNA Damage | 1 | 2022 | 2441 | 0.100 |
Why?
|
Knowledge Bases | 1 | 2012 | 97 | 0.100 |
Why?
|
Protein Processing, Post-Translational | 1 | 2019 | 1974 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6330 | 0.100 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2022 | 3609 | 0.090 |
Why?
|
Nucleosomes | 3 | 2023 | 484 | 0.090 |
Why?
|
Cell Cycle Proteins | 5 | 2022 | 3446 | 0.090 |
Why?
|
Female | 31 | 2024 | 391875 | 0.090 |
Why?
|
Homeodomain Proteins | 4 | 2023 | 2413 | 0.090 |
Why?
|
Cell Hypoxia | 1 | 2013 | 656 | 0.090 |
Why?
|
Down-Regulation | 1 | 2018 | 2911 | 0.090 |
Why?
|
Organoids | 3 | 2022 | 741 | 0.090 |
Why?
|
Apoptosis | 3 | 2023 | 9468 | 0.090 |
Why?
|
Down Syndrome | 1 | 2018 | 898 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 1824 | 0.090 |
Why?
|
RNA, Double-Stranded | 2 | 2021 | 295 | 0.080 |
Why?
|
Neoplasm Transplantation | 3 | 2020 | 2014 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 617 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 3024 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2021 | 6894 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2413 | 0.080 |
Why?
|
Nitriles | 3 | 2019 | 969 | 0.080 |
Why?
|
RNA Polymerase II | 1 | 2013 | 539 | 0.080 |
Why?
|
Cell Line | 5 | 2024 | 15598 | 0.080 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3874 | 0.080 |
Why?
|
DNA | 1 | 2023 | 7208 | 0.080 |
Why?
|
Protein Structure, Tertiary | 1 | 2016 | 3792 | 0.080 |
Why?
|
Gene Regulatory Networks | 2 | 2015 | 1739 | 0.080 |
Why?
|
Stents | 1 | 2020 | 3177 | 0.080 |
Why?
|
Benzamides | 3 | 2019 | 1370 | 0.080 |
Why?
|
Gene Expression | 5 | 2022 | 7582 | 0.080 |
Why?
|
Gene Knockout Techniques | 2 | 2022 | 802 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2021 | 5662 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2024 | 988 | 0.070 |
Why?
|
DNA Methylation | 4 | 2024 | 4383 | 0.070 |
Why?
|
Intestine, Small | 1 | 2014 | 1205 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2020 | 3396 | 0.070 |
Why?
|
Information Storage and Retrieval | 1 | 2013 | 819 | 0.070 |
Why?
|
Interferons | 2 | 2021 | 704 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 22121 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1901 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6908 | 0.070 |
Why?
|
HEK293 Cells | 3 | 2021 | 4277 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5764 | 0.070 |
Why?
|
Chromosome Mapping | 3 | 2023 | 4630 | 0.070 |
Why?
|
Peptides | 1 | 2018 | 4338 | 0.070 |
Why?
|
Promoter Regions, Genetic | 4 | 2019 | 5778 | 0.060 |
Why?
|
Paclitaxel | 2 | 2023 | 1732 | 0.060 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1405 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2423 | 0.060 |
Why?
|
Tamoxifen | 2 | 2022 | 964 | 0.060 |
Why?
|
Aging | 1 | 2024 | 8689 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4020 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6033 | 0.060 |
Why?
|
Methylnitrosourea | 1 | 2024 | 30 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2328 | 0.060 |
Why?
|
Liver | 1 | 2020 | 7531 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2021 | 1355 | 0.060 |
Why?
|
Neoplasm Invasiveness | 2 | 2024 | 3587 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3610 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2020 | 4241 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4879 | 0.060 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2024 | 223 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6128 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2022 | 15867 | 0.050 |
Why?
|
Mammary Glands, Animal | 1 | 2024 | 271 | 0.050 |
Why?
|
Molecular Targeted Therapy | 3 | 2021 | 2805 | 0.050 |
Why?
|
Cytarabine | 1 | 2024 | 697 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2021 | 26 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2021 | 6206 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2024 | 14397 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7424 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2024 | 497 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2024 | 507 | 0.050 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 305 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5359 | 0.050 |
Why?
|
Glucose Transporter Type 1 | 1 | 2022 | 186 | 0.050 |
Why?
|
HT29 Cells | 1 | 2021 | 192 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2022 | 313 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2024 | 80430 | 0.050 |
Why?
|
Deoxycytosine Nucleotides | 1 | 2020 | 14 | 0.050 |
Why?
|
Genes, APC | 1 | 2021 | 144 | 0.050 |
Why?
|
Calmodulin | 1 | 2022 | 218 | 0.050 |
Why?
|
Genes, myc | 1 | 2022 | 390 | 0.050 |
Why?
|
Prognosis | 4 | 2022 | 29551 | 0.050 |
Why?
|
Linkage Disequilibrium | 2 | 2016 | 2004 | 0.040 |
Why?
|
Genes, cdc | 1 | 2020 | 114 | 0.040 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2020 | 57 | 0.040 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2020 | 106 | 0.040 |
Why?
|
Transcription Initiation Site | 1 | 2020 | 188 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2024 | 1340 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2021 | 111 | 0.040 |
Why?
|
Cyclin E | 1 | 2020 | 156 | 0.040 |
Why?
|
Phenylenediamines | 1 | 2020 | 87 | 0.040 |
Why?
|
RNA Interference | 2 | 2021 | 2832 | 0.040 |
Why?
|
Choroid | 1 | 2022 | 352 | 0.040 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2024 | 682 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 401 | 0.040 |
Why?
|
Phosphorylation | 2 | 2024 | 8311 | 0.040 |
Why?
|
Repressor Proteins | 2 | 2022 | 2978 | 0.040 |
Why?
|
Mucin-1 | 1 | 2024 | 539 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2020 | 178 | 0.040 |
Why?
|
Protein Multimerization | 1 | 2024 | 982 | 0.040 |
Why?
|
Breast Neoplasms, Male | 1 | 2021 | 219 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2018 | 1517 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2019 | 72 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 515 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Gene Library | 1 | 2021 | 1059 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2023 | 870 | 0.040 |
Why?
|
Neoplasm Proteins | 2 | 2024 | 3610 | 0.040 |
Why?
|
Acrylamides | 1 | 2020 | 259 | 0.040 |
Why?
|
Chemotaxis | 1 | 2021 | 599 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2022 | 64591 | 0.040 |
Why?
|
Introns | 1 | 2021 | 981 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 502 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5815 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1135 | 0.040 |
Why?
|
Piperazines | 2 | 2021 | 2519 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 331 | 0.040 |
Why?
|
HMGB Proteins | 1 | 2018 | 45 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 113 | 0.040 |
Why?
|
Immune Evasion | 1 | 2021 | 363 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2023 | 1254 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 95 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6471 | 0.040 |
Why?
|
Embryonic Development | 1 | 2022 | 717 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 979 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 856 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1755 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2021 | 1792 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 960 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2016 | 17854 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2021 | 9533 | 0.040 |
Why?
|
Aminopyridines | 1 | 2021 | 570 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 550 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 633 | 0.040 |
Why?
|
Clone Cells | 1 | 2020 | 1660 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2017 | 240 | 0.030 |
Why?
|
Cell Communication | 1 | 2024 | 1652 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4903 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 232 | 0.030 |
Why?
|
GATA3 Transcription Factor | 1 | 2017 | 152 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16585 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2019 | 815 | 0.030 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2016 | 30 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 851 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1083 | 0.030 |
Why?
|
Stem Cells | 2 | 2023 | 3522 | 0.030 |
Why?
|
Gene Dosage | 1 | 2020 | 1218 | 0.030 |
Why?
|
ROC Curve | 1 | 2024 | 3571 | 0.030 |
Why?
|
Data Mining | 1 | 2021 | 551 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2021 | 855 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12698 | 0.030 |
Why?
|
Phosphoserine | 1 | 2016 | 203 | 0.030 |
Why?
|
Genome, Human | 2 | 2021 | 4423 | 0.030 |
Why?
|
Muscles | 1 | 2020 | 1575 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1887 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1717 | 0.030 |
Why?
|
Casein Kinase II | 1 | 2016 | 122 | 0.030 |
Why?
|
Mice, Nude | 1 | 2022 | 3603 | 0.030 |
Why?
|
Metabolism, Inborn Errors | 1 | 2017 | 286 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2020 | 774 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1119 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2468 | 0.030 |
Why?
|
Endonucleases | 1 | 2018 | 369 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 545 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 544 | 0.030 |
Why?
|
Genomics | 2 | 2023 | 5806 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1089 | 0.030 |
Why?
|
Cell Fusion | 1 | 2015 | 294 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2016 | 247 | 0.030 |
Why?
|
Antigens | 1 | 2020 | 1446 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 351 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2016 | 1141 | 0.030 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 223 | 0.030 |
Why?
|
Ligands | 1 | 2021 | 3270 | 0.030 |
Why?
|
Methylation | 1 | 2017 | 1082 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3777 | 0.030 |
Why?
|
Protein Phosphatase 2 | 1 | 2016 | 231 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2625 | 0.030 |
Why?
|
Cell Shape | 1 | 2015 | 370 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 712 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2023 | 2464 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2870 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 931 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9267 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1337 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2015 | 522 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2022 | 2444 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2416 | 0.030 |
Why?
|
Enterocytes | 1 | 2014 | 220 | 0.030 |
Why?
|
Visual Acuity | 1 | 2022 | 2662 | 0.030 |
Why?
|
Estrogens | 1 | 2019 | 1519 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2394 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1647 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2667 | 0.020 |
Why?
|
Genome-Wide Association Study | 3 | 2016 | 12653 | 0.020 |
Why?
|
K562 Cells | 1 | 2013 | 642 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1605 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 1228 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2388 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2202 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2024 | 4413 | 0.020 |
Why?
|
Testosterone | 1 | 2022 | 2471 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2013 | 931 | 0.020 |
Why?
|
Nucleotides | 1 | 2013 | 454 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1850 | 0.020 |
Why?
|
Drug Design | 1 | 2016 | 1050 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1114 | 0.020 |
Why?
|
Mitochondria | 1 | 2024 | 3624 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3075 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2022 | 2529 | 0.020 |
Why?
|
Estradiol | 1 | 2017 | 1935 | 0.020 |
Why?
|
Middle Aged | 5 | 2024 | 220382 | 0.020 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2013 | 653 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18216 | 0.020 |
Why?
|
Trans-Activators | 1 | 2019 | 2858 | 0.020 |
Why?
|
Bacteria | 1 | 2020 | 2217 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3428 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2020 | 5491 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3157 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2803 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2868 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2014 | 743 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 1640 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2020 | 3469 | 0.020 |
Why?
|
Aged | 4 | 2024 | 168840 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23712 | 0.020 |
Why?
|
Breast | 1 | 2017 | 1962 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2020 | 4936 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9309 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2019 | 3661 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2015 | 2104 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 3097 | 0.020 |
Why?
|
Adult | 4 | 2024 | 220781 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2023 | 6475 | 0.020 |
Why?
|
Genetic Loci | 1 | 2016 | 2626 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2691 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5427 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1861 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11096 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13240 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11070 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4748 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74055 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7046 | 0.020 |
Why?
|
Genetic Testing | 1 | 2018 | 3535 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2018 | 3842 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9462 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3092 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2020 | 7849 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18955 | 0.010 |
Why?
|
Child | 2 | 2022 | 80086 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10188 | 0.010 |
Why?
|
Cell Movement | 1 | 2015 | 5198 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22097 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3818 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11729 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12976 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6168 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10180 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39078 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36183 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42209 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41366 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59068 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88196 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36362 | 0.000 |
Why?
|